For the year ending 2025-10-31, ANIX has $16,080K in assets. $2,130K in debts. $1,244K in cash and cash equivalents.
| Balance Sheets | 2025-10-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 1,244 | |||
| Shortterm investments | 13,930 | |||
| Prepaid expenses and other current assets | 713 | |||
| Total current assets | 15,887 | |||
| Operating lease right-of-use asset | 193 | |||
| Total assets | 16,080 | |||
| Accounts payable | 165 | |||
| Accrued expenses | 1,761 | |||
| Operating lease liability | 41 | |||
| Total current liabilities | 1,967 | |||
| Operating lease liability, non-current | 163 | |||
| Total liabilities | 2,130 | |||
| Common stock, par value .01 per share 100,000,000 shares authorized 33,013,829 and 32,196,862 shares issued and outstanding as of october 31, 2025 and 2024, respectively | 330 | |||
| Additional paid-in capital | 266,508 | |||
| Accumulated deficit | -251,677 | |||
| Total shareholders equity | 15,161 | |||
| Noncontrolling interest (note 2) | -1,211 | |||
| Total equity | 13,950 | |||
| Total liabilities and equity | 16,080 | |||
Anixa Biosciences Inc (ANIX)
Anixa Biosciences Inc (ANIX)